The Yorkshire Health Study is a longitudinal observational regional health study collecting health information on the residents from the Yorkshire and Humberside region in England.
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For more information, including our policy and submission procedure, please contact the Repository Team at: E.mailbox@hud.ac.uk. http://eprints.hud.ac.uk/ Humberside region. Data were collected on current and long-standing health, health care usage and health-related behaviours, with a particular focus on weight and weight management. The majority of individuals have also given consent for record linkage with routine clinical data, allowing the linking to disease diagnosis, medication use and health care usage. The study encourages researchers to utilise the sample through the embedding of randomised controlled trials, other controlled trials and qualitative studies. To access the anonymised data or use the sample to recruit participants to studies, researchers should contact Dr Clare Relton (c.relton@sheffield.ac.uk).
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Key Messages
The cohort research platform facilitates multiple randomised controlled trials to be run in the same population. This allows greater comparability between studies.
The cohort offers greater focus for research surrounding obesity and weight management, particularly their association to long-term health conditions. No other cohorts offer the detail required to inform policy decisions in this area.
Analysis of this data set has shown that the health-related quality of life measure EQ-5D to be a useful tool for capturing differences in health and well-being after accounting for various long-standing health conditions.
Why was the cohort set up?
The study began in 2009 as the South Yorkshire Cohort with the aims of collecting information on the health of the residents of South Yorkshire and providing a research platform for the region. In 2014, the study was expanded and rebranded as the Yorkshire Health Study to collect information for the whole of the Yorkshire and Humberside region. A wide range of variables were collected to provide information on demographic characteristics, current and long-standing health, well-being, health care usage and health-related behaviours.
The original focus of the cohort was weight and weight management, particularly the relationships between obesity, health care and long-standing health conditions. This focus was based on the recommendations of the y Weight, Healthy Lives government report which had proposed five key aims for future research to tackle obesity levels in England (1):
A longitudinal approach to research (incorporating the short, medium and long term).
Exploring the association of obesity to other key health issues.
Analysing the impact of policies, with a focus on reducing social inequalities.
Evaluating the effectiveness of long term policies and interventions. experiments
The Yorkshire Health Study allows the investigation of each of these aims through a focused set of variables and a large sample size (2) . The depth of information provided allows a detailed investigation of variations in obesity to other dimensions of health, particularly chronic health conditions. Other population cohort studies are less relevant to fulfilling these identified needs of the National Health Service (NHS) for obesity-related research (for example (3 5) ).
The cohort is uniquely set up to facilitate led approach to experimental research (6). This approach utilises the large cohort study as a research platform to facilitate recruitment to multiple pragmatic randomised controlled trials (with treatment as usual as the control), as well as other health studies. This approach provides a number of benefits to studies utilising the Yorkshire Health Study research platform: detailed information on potential research participants and their efficient (quick and inexpensive) identification and ongoing information as to the natural history of the condition and treatment as usual (2) . The particular benefits for randomised controlled trials include long term outcomes as standard, increased comparability between each trial conducted within the cohort and increased efficiency particularly for expensive or high risk interventions (6).
The study completed its first wave of data collection (2010 to 2012) and the second wave (2013 to 2015) to extend the data longitudinally is ongoing. The study is expected to run for a minimum of ten years. New variables will be added in future waves in response to the findings of research and the recommendations of health and social care commissioning bodies.
Ethical approval for the cohort was obtained from the Leeds East NHS Research Ethics Committee on the 22 th April 2010 (ref: 09/H1306/97).
Who is in it?

Sample region
In the first wave, the sample region was South Yorkshire, an English metropolitan county in the Yorkshire and Humber region in England. It consists of four large urban areas (the metropolitan boroughs of Barnsley, Doncaster and Rotherham, along with the city of Sheffield) and surrounding rural areas, with a total population of 1,343,601 recorded at the 2011 Census. Data were also collected for a small number of residents of Derbyshire. For subsequent waves, the sample region was expanded to the Yorkshire and Humberside Previous research has shown that in much of South Yorkshire and Yorkshire as a whole, rates of obesity are higher than compared to the national average (7) . As such, the sample regions provide a useful setting for a cohort study that has a weight and weight management focus.
Sampling strategy
A two stage approach was used for the initial data collection (2) . Firstly, General Practitioner (GP) surgeries were contacted with a view to participating in the study (43 agreed; 50% acceptance What has been measured? Table 2 summarises the variables collected. The inclusion of 12 long-standing conditions (along with a free-text field for additional conditions) reflects the growing interest in the impact of multi-morbidity (9, 10) . The EuroQoL EQ-5D health-related quality of life questionnaire (11) is included as part of the cohort questionnaire. This measure is used within the NHS and is the National Institute for Health and Care Excellence preferred measure of quality of life in economic evaluations (2, 12) . In order to understand more about NHS and non NHS healthcare resource use, medication usage is also included.
( Table 2 here)
The postcode of the individual allows each record to be geo-located. From this, additional spatial information can be gathered (for example, see Table 1 ; the deprivation measure was collected from area data), allowing the analysis of phenomenon not included in the questionnaire (e.g. exposure to pollution). GP surgery information can also be linked to participants, providing information relating to the characteristics of the primary healthcare provider used by each individual.
Included in the questionnaire is an option for individuals to consent to allow researchers to access their health records. Data linkage of individual records in the cohort to GP clinical records (e.g. morbidity, health care and medication usage) and other sources (e.g. Hospital
Episode Statistics) is possible and discussions are currently ongoing.
The second wave of data collection will collect the variables in the first wave (Table 2) excluding occupation, education or weight management. It will additionally include data on levels of income, provision (and receipt) of informal and formal care of individuals, dietary intake, severity of long-term health conditions, and more detail on physical activity.
What has it found?
With the first wave of cohort data only recently collected, research is at an early stage. The focus so far has been on understanding differences in weight management strategies and exploring the associated factors to health-related quality of life. Some early results from these studies are presented here.
The cohort has been used to help inform the local councils policy development, planning and resource allocation. For example, of health and well-being for Sheffield City Council showed evidence of wide social inequalities in levels of obesity (13) . There were twice as many people classified as obese in the most deprived areas than compared to the least deprived (with the relative difference in the morbidly obese being even greater). The cohort has also been used to provide estimates on the prevalence of long term health conditions and health-related behaviours.
A second study explored the uptake of slimming clubs and weight loss medication (manuscript submitted). There is little evidence surrounding how these weight management strategies varied by demographic factors, particularly deprivation. The study found varying social gradients in the uptake of each strategy independent of age, gender and health ( Figures   1 and 2) , with slimming clubs less likely to be used in deprived areas but weight loss medication more likely to be used (although the effect size for the latter was lower). The results demonstrate the importance of targeting population groups with different strategies to effectively tackle obesity.
( Figures 1 and 2 
here)
A number of studies have focused on the relationship between reported EQ-5D and longstanding health conditions (11) . Firstly, a study examined whether the EQ-5D measure is too narrowly focused to reflect the impact of long-standing health conditions on subjective wellbeing (manuscript submitted). It was observed that long-standing health conditions did not have an independent and consistent impact on life satisfaction. Therefore, it was concluded that the EQ-5D measure is a useful instrument to reflect the impact of health conditions on life satisfaction and no additional dimensions need to be added.
A second study focused on the impact of long-standing health conditions on reported EQ-5D (14) . Previous studies have shown an inconsistent relationship between chronic ill-health and quality of life measures, with the suggestion that this may be due to differences between the studies in the method used to measure quality of life. The analysis showed that the long term conditions pain, depression, anxiety/nerves, and osteoarthritis had the largest negative effect on health-related quality of life (although all long term health conditions measured reported negative effects, independent of socio-demographic factors). These results were consistent across each statistical methodology employed in the analysis.
Researchers have also used the data to assess the relationship between BMI and EQ-5D, and whether the relationship is attenuated by long term health conditions (15) . A deviation from a healthy weigh ) was found to have a negative effect on healthrelated quality of life (EQ-5D) independent of social, demographic and health factors.
Removing each long term health condition from the analysis (compared to a single variable for long term condition) allowed an assessment to be made regarding the effect it had on the relationship association between BMI and EQ-5D for individuals with a BMI 2 ( Figure 3 ). Diabetes, heart disease, osteoarthritis and high blood pressure were important mediating factors in the relationship and the results were consistent across each dimension of EQ-5D.
( Figure 3 here) A number of research groups have used the platform to identify and invite potential participants to their studies. Researchers investigated how people make decisions concerning weight management (16) . Decisions were found to be impacted by stigma surrounding obesity, as negative feelings affected clear thinking in the choices individuals made. Drawing on their findings, a decision aid booklet was created to help influence individuals to make good decisions about their weight control. The results also led to the development of a questionnaire to assess the impact of obesity stigma (17) .
The first randomised controlled trial utilising the cohort multiple randomised controlled trial design is now being implemented (6). This trial is testing the effectiveness of treatment by homeopaths for people with self-reported depression (DEPSY) http://www.controlledtrials.com/ISRCTN02484593).
A list of current projects can be viewed at http://www.yorkshirehealthstudy.org/#!yourresearch-studies/c17r5.
What are the main strengths and weaknesses?
Strengths:
A large sample size covering a wide range of population sub-groups.
Longitudinal design for data collection.
Data collected on a broad range of health related variables.
A research platform designed to facilitate the running cohort multiple randomised controlled trials and facilitate participant identification and recruitment to health related research (6).
Consent to link the majority of individuals to their NHS health records.
Questions designed to be policy relevant, to encourage the collaboration between academia, local authorities and the NHS.
Weaknesses:
Some demographic bias with a higher proportion of elderly, female, White ethnicities and individuals from less deprived areas. This was partly due to the low response rate.
The first wave was collected over three years, rather than at a single time point.
Can I get hold of the data? Where can I find more?
The data are managed by . 
